Form 4 for ORGO Organogenesis Holdings Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-15 · accession 0001062993-25-002937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-02-19 | 2025-02-15+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.70 | -232.1K | 2.96M | -7% | -$858.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-02-16 | F | D | 6,123 | $3.70 | 2,807,108 | D | — | — | |
| 2 | Common | Class A Common Stock | 2025-02-15 | F | D | 33,869 | $3.70 | 2,813,231 | D | — | — | |
| 3 | Common | Class A Common Stock | 2025-02-15 | F | D | 109,280 | $3.70 | 2,847,100 | D | — | — | |
| 4 | Common | Class A Common Stock | 2025-02-15 | F | D | 82,814 | $3.70 | 2,956,380 | D | — | — |